Internal Medicine · Homewood, AL
NPI
1588634679
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10 Old Montgomery Hwy Ste 100
Homewood, AL, 35209
Phone (205) 949-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
76,533 services
Medicare patients, 2024
304
Average age 74
Drug cost, 2024
$1.5M
13,600 prescriptions
Company payments, 2025
$6,732
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry K McLean was code J1071 (injection, testosterone cypionate, 1 mg), 72,502 times for 26 patients. In total Barry K McLean billed 76,533 services in 71 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 72,502 | 26 | $0.02 | $1,235 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,240 | 29 | $0.09 | $117 |
| 99214 Office E&M - Established | Office | 557 | 284 | $72.06 | $40K |
| 96372 Injection Administration | Office | 374 | 78 | $8.84 | $3,306 |
| 83036 Blood Count | Office | 258 | 118 | $9.52 | $2,456 |
| 82947 Clinical Chemistry | Office | 240 | 112 | $3.85 | $924 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 210 | 210 | $113.30 | $24K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 210 | 210 | $16.19 | $3,399 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 144 | 32 | $0.31 | $44.62 |
| 99213 Office E&M - Established | Office | 122 | 78 | $54.61 | $6,662 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 100 | 32 | $0.87 | $87.38 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 90 | 27 | $4.65 | $419 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 64 | 46 | $38.23 | $2,447 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 41 | 18 | $68.18 | $2,795 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 29 | 15 | $23.85 | $692 |
By year: 2022 $132K for 80,701 services; 2023 $114K for 86,764 services; 2024 $103K for 76,533 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 258 | 118 | $9.52 | $2,456 |
| 82947 Clinical Chemistry | 240 | 112 | $3.85 | $924 |
Medicare prescription drug claims, 2024
In 2024, the drug Barry K McLean prescribed most often to Medicare patients was Atorvastatin Calcium, with 632 prescriptions and refills. In total Barry K McLean wrote 13,600 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 632 | 1,747 | 211 | $9,258 |
| Alprazolam Generic | 475 | 539 | 71 | $2,214 |
| Tramadol Hcl Generic | 374 | 382 | 75 | $3,422 |
| Levothyroxine Sodium Generic | 361 | 924 | 111 | $5,010 |
| Gabapentin Generic | 348 | 566 | 80 | $4,796 |
| Amlodipine Besylate Generic | 329 | 912 | 109 | $2,851 |
| Montelukast Sodium Generic | 296 | 788 | 95 | $4,435 |
| Zolpidem Tartrate Generic | 289 | 368 | 49 | $1,966 |
| Clonazepam Generic | 251 | 343 | 49 | $2,132 |
| Metformin Hcl Generic | 246 | 706 | 84 | $3,375 |
| Pantoprazole Sodium Generic | 238 | 627 | 76 | $3,668 |
| Rosuvastatin Calcium Generic | 231 | 651 | 69 | $4,978 |
| Mounjaro Tirzepatide | 223 | 260 | 44 | $277K |
| Ezetimibe Generic | 216 | 594 | 61 | $6,410 |
| Carvedilol Generic | 187 | 453 | 62 | $2,023 |
Brand drugs: 1,964 claims; generic drugs: 11,543 claims; opioid claims: 388.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry K McLean $6,732 ($1,408 in general payments such as food, travel and fees and $5,324 for research) from 26 companies. The largest payer was F. Hoffmann-La Roche AG with $5,324.
| Company | Payments | Amount |
|---|---|---|
| F. Hoffmann-La Roche AG ROG.SW | 2 | $5,324 |
| Novo Nordisk Inc NVO | 8 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $185 |
| Lilly USA, LLC LLY | 11 | $168 |
| Pfizer Inc. PFE | 5 | $113 |
| Amgen Inc. AMGN | 6 | $105 |
| Exact Sciences Corporation EXAS | 4 | $69.83 |
| Corcept Therapeutics CORT | 3 | $66.42 |
| Antares Pharma, Inc. | 3 | $62.71 |
| Boston Scientific Corporation BSX | 3 | $61.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.